Seeking Alpha

Sinovac Biotech EPS of $0.02, beats on revenues

  • Sinovac Biotech (SVA): Q2 EPS of $0.02 beats by $0.08.
  • Revenue of $17.5M (+86.4% Y/Y) beats by $5.88M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: